Lisa A. Vandermeer

Ottawa, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications

Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.

Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.

Journal: NEJM evidence
Published: May 26, 2026

A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes.

A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes.

Journal: Current oncology (Toronto, Ont.)
Published: February 20, 2026

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study.

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study.

Journal: Journal of medical Internet research
Published: November 29, 2025

Prognostic and predictive performance of PREDICT 2.1, PREDICT v3, and RSClin in node-negative early breast cancer: a TEAM pathology substudy.

Prognostic and predictive performance of PREDICT 2.1, PREDICT v3, and RSClin in node-negative early breast cancer: a TEAM pathology substudy.

Journal: Breast cancer research and treatment
Published: November 20, 2025

Comparative Effectiveness of Interventions to Treat Cancer Treatment-Related Cognitive Impairment in Adult Cancer Survivors Following Systemic Therapy: A Systematic Review with Network Meta-Analyses.

Comparative Effectiveness of Interventions to Treat Cancer Treatment-Related Cognitive Impairment in Adult Cancer Survivors Following Systemic Therapy: A Systematic Review with Network Meta-Analyses.

Journal: Cancers
Published: September 22, 2025

REaCT-5G: a randomized trial of bone pain with 5-day filgrastim vs pegfilgrastim for neutropenia in breast cancer.

REaCT-5G: a randomized trial of bone pain with 5-day filgrastim vs pegfilgrastim for neutropenia in breast cancer.

Journal: JNCI cancer spectrum
Published: May 22, 2025

Do regularly scheduled visits result in earlier detection of curable breast cancer recurrences?

Do regularly scheduled visits result in earlier detection of curable breast cancer recurrences?

Journal: Breast cancer research and treatment
Published: March 24, 2025

Patient perceptions around the use of clinico-pathologic and genomic tools in the management of early breast cancer.

Patient perceptions around the use of clinico-pathologic and genomic tools in the management of early breast cancer.

Journal: Breast cancer research and treatment
Published: March 21, 2025

A pragmatic, multicenter, randomized trial comparing morning versus evening dosing of adjuvant endocrine therapy (REaCT-CHRONO Study).

A pragmatic, multicenter, randomized trial comparing morning versus evening dosing of adjuvant endocrine therapy (REaCT-CHRONO Study).

Journal: NPJ breast cancer
Published: January 10, 2025

A Multicenter Physician Survey Evaluating the Use of Ki-67 in Breast Cancer Management in Canada.

A Multicenter Physician Survey Evaluating the Use of Ki-67 in Breast Cancer Management in Canada.

Journal: Biomedicines
Published: October 04, 2024

Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study.

Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study.

Journal: Journal of medical Internet research
Published: September 24, 2024

Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?

Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?

Journal: Breast (Edinburgh, Scotland)
Published: August 25, 2024
Showing 1-12 of 107

Last Updated: 09/26/2026